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Abstract
Background and Aims: Morphological changes during human and mouse esophageal development have been well
characterized. However, changes at the molecular level in the course of esophageal morphogenesis remain unclear. This
study aims to globally profile critical genes and signaling pathways during the development of mouse esophagus. By using
microarray analysis this study also aims to determine how the Nrf2/Keap1 pathway regulates the morphogenesis of the
esophageal epithelium.
Methods: Gene expression microarrays were used to survey gene expression in the esophagus at three critical phases:
specification, metaplasia and maturation. The esophagi were isolated from wild-type, Nrf2
2/2, Keap1
2/2,o rNrf2
2/2Keap1
2/
2 embryos or young adult mice. Array data were statistically analyzed for differentially expressed genes and pathways.
Histochemical and immunohistochemical staining were used to verify potential involvement of the Wnt pathway, Pparb/d
and the PI3K/Akt pathway in the development of esophageal epithelium.
Results: Dynamic gene expression patterns accompanied the morphological changes of the developing esophagus at
critical phases. Particularly, the Nrf2/Keap1 pathway had a baseline activity in the metaplasia phase and was further
activated in the maturation phase. The Wnt pathway was active early and became inactive later in the metaplasia phase. In
addition, Keap1
2/2 mice showed increased expression of Nrf2 downstream targets and genes involved in keratinization.
Microarray and immunostaining data also suggested that esophageal hyperkeratosis in the Keap1
2/2 mice was due to
activation of Pparb/d and the PI3K/Akt pathway.
Conclusions: Morphological changes of the esophageal epithelium are associated with dynamic changes in gene
expression. Nrf2/Keap1 pathway activity is required for maturation of mouse esophageal epithelium.
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Introduction
Morphological changes in developing human organs require
coordinated activation of gene transcription and signaling
pathways [1]. The epithelial cells lining the human esophagus
transform from simple columnar into ciliated epithelium at an
early phase. The ciliated epithelium is then gradually replaced by a
squamous epithelium until a non-keratinized stratified squamous
epithelium. Morphological changes during human esophageal
development have been well-characterized for several decades
[2,3]. However, the molecular mechanisms underlying these
morphological changes remain largely unknown.
Studies using mouse genetic models provided initial insights into
the roles of transcription factors and signaling pathways for the
morphogenesis of the esophagus [4,5]. The esophagus is specified
from the foregut tube at embryonic day E9.5 in mice, and at four
weeks in humans. In mouse embryo, the esophagus is completely
separated from the trachea at E11.5. Mutation of genes encoding
transcription factors (e.g., Sox2 and Ttf1) and signaling molecules
(e.g., Noggin, Shh) disrupts the separation process, leading to the
formation of esophageal atresia [6]. From E11.5 to E15.5 the
esophageal epithelium is transformed from a simple columnar
epithelium to a multiple-layered epithelium. Towards the end of
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markers and express squamous cell markers. From E15.5 to birth,
columnar features are almost lost and the epithelium is further
stratified. From postnatal day 7 (P7) onwards, the top layer of the
stratified squamous epithelium starts the enucleating process and
forms a keratin layer which is not present in the human esophagus
[5,7,8,9].
According to these morphological changes, the development of
the esophagus can be divided into three phases: specification phase
(E9.5–11.5), metaplasia phase (E11.5-P7), and maturation phase
(P7-adult). Our previous studies showed that Bmp signaling plays a
two-stage role in the developing esophagus [4]. During the early
metaplasia phase (E11.5–15.5), the Bmp pathway is inhibited by
Noggin to allow stratification to occur. Subsequently, the Bmp
pathway must be activated to promote squamous differentiation of
the top layers of the stratified epithelium [4]. Interestingly, other
signaling pathways including Wnt pathway and Shh pathway are
active in the separating esophagus at the early specification phase
(reviewed by Morrisey and Hogan [10]). Nevertheless, it is
unknown whether these signaling molecules assume a dynamic
change of expression pattern similar to Bmps.
In our previous study on human Barrett’s esophagus, a
metaplastic condition in which the stratified squamous epithelium
of the lower esophagus is replaced by intestinalized columnar
epithelium, we found that several transcription factors such as Nrf2
(nuclear factor erythroid derived 2 like 2, or Nfe2l2) and small Maf
proteins (MafF, MafG) were enriched in the normal human
esophagus as compared with Barrett’s esophagus [11]. As a major
cellular defense pathway, the Nrf2/Keap1 (kelch-like ECH-
associated protein 1) pathway is known to regulate expression of
enzymes involved in detoxification and anti-oxidative stress
response [12]. Nrf2 forms heterodimers with small Maf proteins
and binds to the antioxidant-responsive elements of target genes
when cells are exposed to oxidative stress or xenobiotics. Keap1
regulates the function of Nrf2 by retaining Nrf2 in the cytoplasm
under normal physiological conditions, and by allowing nuclear
translocation of Nrf2 under stress conditions. Certain Keap1
mutants have a dominant-negative effect on wild-type Keap1
[13]. In addition to its function in stress response, the Nrf2/Keap1
pathway is known to participate in wound healing, inflammation
resolution, apoptosis, and keratinocyte differentiation [14].
Nrf2
2/2 mice developed normally. Keap1
2/2 mice died within
three weeks after birth, probably due to malnutrition as a result of
hyperkeratosis in the esophagus and forestomach. In the
esophageal epithelium, Keap1
2/2 mice expressed higher levels of
Krt1, Krt6 and Lor and lower levels of Krt13 and Inv than the wild-
type mice. These phenotypes were due to superactivation of Nrf2
with the help of small Maf proteins because both Nrf2
2/2Keap1
2/
2 and MafF:MafG:Keap1
2/2 rescued the Keap1
2/2 phenotype
[15,16]. These studies clearly indicate that the Nrf2/Keap1
pathway plays a critical role in the development of esophageal
epithelium.
In this study, we examined gene expression in the esophagi of
wild-type and mutant mice (Nrf2
2/2, Keap1
2/2 and Nrf2
2/
2Keap1
2/2) using gene microarrays. Our goal was to survey gene
expression during the development of mouse esophageal epithe-
lium, and to better understand the role of the Nrf2/Keap1
pathway in the process.
Materials and Methods
Animals
Wild-type C57BL/6J mice were purchased from the Jackson
Laboratory (Bar Harbor, ME). Nrf2
2/2 and Keap1
+/2 mice on
C57BL background were obtained from the Experimental Animal
Division, RIKEN Biosource Center (Tsukuba, Japan) [15]. BAT-
GAL and TOP-GAL mouse lines were purchased from the
Jackson Laboratory, and they were maintained on C57BL/6 and
CD1 background, respectively [17,18].
These mice were bred in-house to generate embryos and
offspring with proper genotypes. Mice were PCR-genotyped
according to protocols provided by the original developers.
Esophagi of E11.5, E15.5, P0, P7, and adult (8 weeks old) mice
were dissected and snap-frozen for future extraction of total RNA.
Part of each esophagus was fixed in 10% buffered formalin or
frozen for future use in histology. Three esophageal samples from
each group at each time point were harvested. The following tissue
samples were harvested for gene expression profiling: (1) wild-type
esophagi at E11.5, E15.5, P0, P7; (2) wild-type, Nrf2
2/2, Keap1
2/2
and Nrf2
2/2Keap1
2/2 esophagi at P7; (3) wild-type and Nrf2
2/2
adult esophageal epithelium (see Figure 1A for the sampling
scheme). All animal experiments were approved by the Institu-
tional Animal Care and Use Committees (IACUC) at the
University of Rochester and North Carolina Central University
(protocol number XC-12-03-2008).
RNA isolation and quality check
Total RNA was extracted from individual mouse esophagi
(E11.5, E15.5, P0, P7 and adult) with an RNeasy Fibrous Tissue
Mini Kit (Qiagen; Valencia, CA). These RNA samples were
checked for their quality using gel electrophoresis, and their
concentrations were measured using spectrophotometry. Their
quality (RIN.7) was further checked with Bioanalyzer (Agilent
Technologies; Santa Clara, CA) at the Genomics Core Facility,
Lineberger Comprehensive Cancer Center, University of North
Carolina at Chapel Hill.
Microarray data collection, data pre-processing and
probe annotation
Microarray experiments were performed at the Genomics Core
Facility with Agilent two-channel mouse 4644k microarrays. Red
channel (Cy5) was used for esophageal samples, and green channel
(Cy3) for mouse universal reference RNA (provided by the
Genomics Core Facility). Hybridization was performed according
to the standard protocol of ‘‘Two-Color Microarray-Based Gene
Expression Analysis’’ for Agilent Gene Expression Oligo micro-
arrays Version 5.0.1. Briefly, a 26 target mix was generated
containing 125 ng cyanine 3- labeled cRNA, 125 ng cyanine 5-
labeled cRNA, appropriate amounts of labeled synthetic target,
and 25 ml of Agilent’s 106 control solution in a final volume of
125 ml. The sample was then fragmented by the addition of 5 ml
256 fragmentation buffer followed by incubation at 60uC for
30 minutes. Samples were moved to ice, and fragmentation was
stopped by addition of 125 ml of Agilent’s 26in situ hybridization
buffer. Microarrays were hybridized in Agilent Microarray
Hybridization Chambers for 17 hours at 60uC with mixing on
an Agilent Rotator in a Robbin’s Scientific Hybridization Oven.
After hybridization, the arrays were scanned by an Axon GenePix
4000B scanner (Axon Instruments; Foster City, CA). The images
were analyzed using Gene Pix Pro 5.0 software (Axon Instru-
ments). Gene expression values were quantified by log base 2 ratio
of red channel intensity (mean) and green channel intensity
(mean), followed by Lowess normalization to remove the intensity-
dependent dye bias. The raw data was submitted to NCBI’s GEO
database (Series GSE34278).
Data pre-processing was carried out via the UNC Microarray
Database for quality filtering and data normalization. UNC
Microarray Database (https://genome.unc.edu/) provides the
Nrf2 in Mouse Esophageal Development
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e36504service for microarray data storage, retrieval, analysis, and
visualization to registered UNC-Chapel Hill researchers and their
collaborators. Agilent array data was extracted on the probe level.
For probes spotted multiple times, the mean expression value was
computed and retained. All probe sequences were BLAT against
the NCBI database [19] and were annotated with Entrez ID.
When multiple probes were targeted on the same gene (with the
same Entrez ID), these data were collapsed onto the Entrez ID,
and mean values were computed as the gene expression value.
Obtaining differentially expressed gene (DEG) and
multivariate analyses
Pre-processed data were used to construct a series of data matrix
files for further analysis. For a given data matrix, the rows were
excluded if more than 40% of missing values were observed. The
rest of missing data was imputed with a K-nearest neighbor (k=9)
approach. DEGs were obtained from two-class and multi-class
statistical modeling using SAM (R package samr v.1.25) [20].
DEGs were obtained based on the corrected p-value#0.05. When
SAM was performed with Excel, DEGs were generated with the
median number of false positives less than 1. To perform
hierarchical clustering analysis [1,21,22], a data matrix with
DEGs only was extracted, row median-centered and column-
standardized. Clustering analysis was also performed with R
(2.10.0). A separate principal component analysis (PCA) was
further performed on each DEG dataset using the R bio3d
package. PCA plots on the first three components were reported,
and a scree plot was reported showing the accumulated variability
explained by the first three principal components.
Extraction of gene expression patterns
In order to show overall trends of the gene expression profile
across the metaplasia phase, a pattern extraction method, the
EPIG process, was applied [23]. Preprocessed and normalized
data matrix and experimental design files were loaded into ExP
software [24], the expression profile of each gene was compared
exhaustively against all other genes, and statistically significant
‘‘profile patterns’’ were self-extracted and stored. Then the genes
whose expression profiles supported the ‘‘profile patterns’’ were
retained in their corresponding profile pattern gene lists and
reported. Expression data matrices of the significant gene
expression patterns obtained from EPIG were loaded into
GeneSpring (Agilent Technologies) for pattern visualization.
Gene set analysis (GSA)
GSA was carried out using R (GSA package). Curated gene sets
in three major categories - canonical pathway (CP; 880 gene sets),
transcription factor targets (TF; 615 gene sets), and Gene
Ontology (GO; C5, 1,454 gene sets) - were downloaded from
the GSEA web portal and used in this study (http://www.
broadinstitute.org/gsea/index.jsp). Both two-class unpaired and
multi-class comparisons were implemented based on the experi-
mental design. 100 permutations were applied to generate a null
distribution for statistical testing, and significantly enriched gene
sets were obtained at a false discovery rate cutoff of 0.05–0.5. To
ensure the validity of the analysis, in addition to the recommended
GSA analysis, each analysis was repeated 100 times and the gene
sets that showed in ,10% of the repetitive studies were excluded
from the final report. When GSA was performed in Excel,
Figure 1. Changes in histology during mouse esophageal development and sampling scheme in this study. (A) Three esophageal
samples in each group at each time point were used for analysis. (B–I) H&E staining of paraffin sections of mouse esophagus showed histological
changes of esophageal epithelium and mesenchyme in metaplasia phase (E11.5, E15.5, P0 and P7). Panel F, G, H and I (size bar=20 mm) are
magnifications of Panel B, C, D and E (size bar=100 mm), respectively. Es, esophagus; Tr, trachea; Ep, epithelium; Me, mesenchyme.
doi:10.1371/journal.pone.0036504.g001
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discovery rate #0.5.
In addition, Fisher’s exact test was performed against ten
knowledge-based gene sets. These knowledge-based gene sets were
manually collected from the literature. These genes are related to
the structure of keratinized stratified squamous epithelium (i.e.,
basal lamina, basal layer, granular layer, spinous layer and
keratinized layer), the epidermal differentiation complex (EDC),
P63 target genes, Sox2 target genes, Pax9 target genes, and Nrf2/
Keap1 target genes (Excel S1). P-values were reported based on
the hypergeometric distribution, and gene sets with p-value#0.05
were reported as significantly enriched gene sets within the DEG
list.
Analysis of archival data from the public database
Differential gene expression between E8.25 definitive endoderm
and E11.5 esophagus has been studied previously using an
Illumina Ambion microarray [8]. Raw microarray data of this
study were downloaded from the Gene Expression Omnibus
(GSE13040) under the accession numbers GSM326633–35
(E8.25) and GSM326642–44 (E11.5). Only probes which were
significantly different from the background were used (p-
value,0.05). To generate ratio data, the intensity of each probe
on a single array was divided by the average intensity of the same
probe on the rest of the arrays. Entrez ID was also used in Illumina
Ambion microarray data. For probes without Entrez ID, GenBank
accession numbers were used and then converted to Entrez ID.
Real-time PCR
cDNA was prepared from DNase-treated total RNA using the
Advantage RT-for-PCR Kit (Clontech; Mountain View, CA).
TaqManH Gene Expression Assays (FAM
TM dye-labeled) with
pre-designed primers for each target gene were obtained from
Applied Biosystems (Foster City, CA). The six target genes were:
Pax9 (paired box gene 9, Assay ID: Mm00440629_m1); Calm4
(calmodulin 4, Assay ID: Mm00490975_s1); Sbsn (suprabasin;
Assay ID: Mm00552057_m1); Ppard (peroxisome proliferator
activator receptor delta, Assay ID: Mm00803184_m1); Pten
(phosphatase and tensin homolog, Assay ID: Mm00477208_m1);
Akt2 (thymoma viral proto-oncogene 2: Mm02026778_g1). 18S
(18S ribosomal RNA;hypothetical LOC790964, Assay ID:
Mm03928990_g1) was used as the endogenous control. Relative
quantitative real-time PCR was performed using an ABI 7900HT
Fast Real-Time PCR System (Applied Biosystems) with SDS v2.3
software. The real-time data exported from RQ Manager 1.2 were
further analyzed by DataAssist 3.0 (Applied Biosystems) to
generate the RQ Plot.
Histochemical and immunohistochemical staining
Tissues were routinely processed for paraffin sectioning (5 mm).
H&E staining was carried out using a standard protocol. For X-
Gal staining, mouse esophagi were isolated and fixed in 4%
paraformaldehyde at 4uC for 20 min on ice. Staining and
subsequent sample processing were performed as previously
described [4,6].
For immunohistochemical staining, the deparaffinized sections
were submerged in methanol containing 0.3% hydrogen peroxide
for 15 min at RT to inhibit endogenous peroxidase activity.
Antigen retrieval was done prior to incubation with rabbit
polyclonal anti-Nrf2 (#PA1-38312, 1:40; Thermo Scientific,
Waltham, MA), or rabbit polyclonal anti-Pparb/d (#LS-B45,
1:1,000; LifeSpan Biosciences, Seattle, WA), or rabbit polyclonal
anti-pAkt(Ser473) (#3787, 1:25; Cell Signaling Technology,
Danvers, MA), overnight at 4uC. Tissue sections were then
washed again in PBS and incubated with peroxidase-conjugated
secondary antibodies for 30 minutes at 37uC. Detection of the
antibody complex was done using the streptavidin-peroxidase
reaction kit with DAB as a chromogen (ABC kit; Vector Labs,
Burlingame, CA). To ensure the specificity of the primary
antibody, control tissue sections were incubated in the absence
of primary antibodies.
Results
In this study, we divided the developmental process of mouse
esophageal epithelium into three phases based on morphological
changes (Figure 1A): (a) The specification phase is defined as the
phase during which the definitive endoderm differentiates into the
esophagus. Two time points, E8.25 and E11.5, were chosen to
represent this phase. (b) The metaplasia phase is defined as the
phase during which the simple columnar epithelium in the
esophagus undergoes metaplastic changes (stratification, squama-
tion and keratinization) into a keratinized stratified squamous
epithelium. Four time points, E11.5, E15.5, P0 and P7, were
selected to represent this phase. (c) The maturation phase is
defined as the phase during which the keratinized stratified
squamous epithelium continues to thicken and finally forms the
esophageal epithelium in adults. Two time points, P7 and adult,
were selected to represent this phase. In the metaplasia phase, the
esophagus is covered by a simple columnar epithelium surrounded
by a well-defined but undifferentiated mesenchyme at E11.5
(Figure 1B, F). At E15.5, it becomes stratified, consisting of ,3 cell
layers, with well-defined submucosa and muscle (Figure 1C, G). At
P0, epithelial cells lose columnar features and appear squamous.
The esophagus is covered by a stratified squamous epithelium with
3–5 cell layers surrounded by a mesenchyme consisting of thicker
muscle (Figure 1D, H). At P7, a keratinized layer has clearly
formed at the surface of the epithelium, and the base membrane
and submucosal papillae are well-formed (Figure 1E, I).
1. Gene expression profiles during the development of
wild-type mouse esophagus
a. Specification phase. Two-class SAM analysis identified
1,612 genes up-regulated and 1,303 genes down-regulated in
E11.5 esophagi as compared with E8.25 definitive endoderm
(Excel S2). Hierarchical clustering analysis and PCA analysis
showed that E8.25 definitive endoderm and E11.5 esophagus were
clustered separately (Figure S1). Among the up-regulated genes,
Irf6, Sox21, Nfib, Upk2, Hoxa5, Sox2, P63, Foxq1, Hoxa2, Hoxa4,
Ovol2, Emp1, Lhfp, Kremen2, Twist1, Rarb, Hoxb4, Nfe2l3, Erf and
Hoxc6 were reported exclusively or highly expressed in E11.5
esophagus as compared to other definitive endoderm-derived
organs [8]. Furthermore, several signaling pathway-related genes,
such as Klf5 (TGFb signaling), Shh and FoxA2 (Hedgehog
signaling), and b-catenin (Wnt signaling), were up-regulated in
E11.5 esophagus as compared with E8.25 definitive endoderm,
suggesting these pathways were likely involved in esophageal
specification.
GSA analysis identified multiple enriched gene sets in the
categories of canonical pathway, gene ontology and transcription
factor (Excel S2). For example, GO_629 (morphogenesis of an
epithelium), GO_727 (epidermis development), and GO_1049
(ectoderm development) were enriched in E11.5 esophagus.
However, using Fisher’s exact test, only P63 target genes were
significantly different between E8.25 definitive endoderm and
E11.5 esophagus (Excel S2).
b. Metaplasia phase. Multi-class SAM analysis identified
2,076 DEGs at this phase (Excel S3). Hierarchical clustering and
Nrf2 in Mouse Esophageal Development
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e36504PCA analysis clearly showed that three samples at each time point
were clustered together (Figure S2). As expected, E11.5 and E15.5
were separated from P0 and P7. Among the 2,076 DEGs, many
genes are known to be involved in differentiation and function of
keratinocytes; these processes include keratinization (Cnfn, Ctnnd,
Evpl, Fgf10, Krt10, Krt17, Krt36, Krt79, Krt80, Krt84, Ppl, Ptch1,
Tgfb2), gap junction (Csda, Gjb2, Gjb3, Gjb4 Gjb6, Gjd4), muscle
development (Mybpc2, Mybph, Myh1, Myh10, Myh2, Myl1, Myl3,
Myo18b, Myo5b, Myo6, Myom1, Bmp4), blood vessel development
(Tgfbr3, Tgm2, Fgf10, Col3a1, Edn1, Edn2, Epas1, Agt), and neuron
development (Bdnf, Cacng4, Dlx2, Dmd, Epha7, Erbb3, Hoxb3, Nrtn).
Eighteen gene expression patterns were extracted from DEGs
(Excel S4). Pattern 1 showed 763 genes up-regulated from E11.5
to P0, and Pattern 2 showed 369 genes down-regulated from
E11.5 to P0. These genes were associated with metaplasia. Pattern
4 (188 genes), Pattern 11 (65 genes), Pattern 13 (33 genes), Pattern
15 (13 genes), and Pattern 16 (7 genes) were up-regulated from
E11.5 to E15.5 and stayed at the same level or were down-
regulated after E15.5. Genes in Pattern 7 (5 genes), Pattern 12 (18
genes), and Pattern 17 (5 genes) were down-regulated from E11.5
to E15.5 and stayed at the same level afterwards. These genes were
probably involved in stratification of columnar epithelial cells.
From E15.5 to P0, Pattern 3 (180 genes), Pattern 8 (40 genes),
Pattern 10 (37 genes) and Pattern 15 were up-regulated, and
Pattern 5 (79 genes), Pattern 11, Pattern 13 and Pattern 16 (7
genes) were down-regulated. These genes were probably involved
in squamation. From P0 to P7, Pattern 6 (51 genes), Pattern 12 (18
genes), Pattern 14 (16 genes), and Pattern 18 (5 genes) were up-
regulated, and Pattern 9 (18 genes), Pattern 10, Pattern 11, and
Pattern 15 were down-regulated. These genes were probably
involved in keratinization, as supported by the fact that genes in
Pattern 1, Pattern 3, Pattern 4, Pattern 6 were generally up-
regulated from E11.5 to P7. As expected, these genes (Muc4, Ppl,
Arg1, Ocln, Bmp6, Tchh, Trp73, Lces, Krts, Sprrs) were known to be
associated with keratinized stratified squamous epithelium.
We collated ten knowledge-based gene sets from the literature
(Excel S1). These gene sets are associated with differentiation of
the skin, the esophagus and the tongue, all of which are covered by
keratinized stratified squamous epithelia. Fisher’s exact test of our
data showed that nine gene sets were significantly associated with
esophageal development in the metaplasia phase: basal lamina
genes, basal layer genes, granular layer genes, keratinized layer
genes, EDC genes, P63 target genes, Pax9 target genes, Sox2 target
genes and Nrf2/Keap1 pathway genes (Table 1). The expression
patterns of these gene sets throughout the metaplasia phase were
generated by GeneSpring to demonstrate dynamic changes (Excel
S4). It is clear that genes of EDC and epithelial layers were
generally up-regulated throughout this phase. This is consistent
with the morphological change of esophageal epithelium: the
transition from simple columnar epithelium to keratinized
stratified squamous epithelium. Pax9 target genes were also
generally up-regulated during the metaplasia phase, suggesting a
critical role of Pax9 in esophageal epithelial differentiation. Real-
time PCR confirmed increasing expression of Pax9 and its
downstream keratinization-associated genes (Calm4 and Sbsn) from
E15.5 to P7 (Figure S3).
In order to explore potential involvement of biochemical
pathways, signaling pathways and transcription factors, multi-class
and two-class GSA analyses were performed (Excel S3). It is clear
that from E11.5 to E15.5, the epithelial structure gene sets
(GO_55, GO_60, GO_66, GO_727), glutathione transfer gene set
(Nrf2-relevant, GO_1418), and Ppar signaling pathway (CP_80)
were up-regulated, while TGFb signaling pathways (CP_110,
CP_381, CP_699) were down-regulated. From E15.5 to P0, a
keratinocyte gene set (CP_295) was up-regulated. The TLR and
NFkB pathways (CP_122, CP_312, CP_392, CP_727, CP_728,
CP_730, CP_838) were up-regulated from E15.5 to P0, and
several of these were down-regulated from P0 to P7. The Wnt
pathway (CP_851) and Hedgehog pathway (CP_170, CP_109)
were down-regulated in P7 as compared with E11.5. These data
suggest that Wnt, NFkB, TGFb, Hedgehog and Nrf2/Keap1
pathways are very likely involved in the metaplasia phase during
the development of esophageal epithelium.
Using the Wnt pathway as an example, we examined its
potential involvement in esophageal epithelial development using
two mouse lines (BAT-lacZ and TOPGAL) that have been
routinely used to report Wnt signaling [17,18]. Consistent with the
microarray data, both mouse lines indicated that Wnt signaling
was active in the developing esophagus between E11.5–E13.5.
Sections of X-gal stained sample showed that Wnt signaling was
limited to the epithelium at E11.5. At E13.5 minimal activity was
also noticed in the mesenchyme, whereas the epithelium remained
strongly positive for X-gal staining (Figure 2). After E13.5, Wnt
activity decreased in the epithelium, and activity disappeared at
E17.5.
c. Maturation phase. Comparing wild-type P7 with adult,
we found 1,248 genes up-regulated and 587 genes down-regulated
in adult esophageal epithelium. Among the up-regulated genes,
many were known Nrf2 target genes, such as Akr1b8, Aldhs, Mts,
Hmox1, Gsts, Abccs, Nqo1, Ltb4dh and Nrf2 itself. GSA analysis shows
that four Nrf2-relevant pathways (CP_29, CP_67, CP_68,
CP_530) were up-regulated in adult esophagi as compared to P7
esophagi. Ppar signaling pathways (CP_80, CP_101, CP_623)
were up-regulated, and Notch signaling (CP_108, CP_696) was
down-regulated (Excel S5). Fisher’s exact test showed that the
Nrf2/Keap1 pathway, basal lamina genes, basal layer genes,
granular layer genes, spinous layer genes and P63 target genes
were significantly enriched in the adult epithelium (Excel S5).
These data suggest that in the maturation phase the Nrf2/Keap1
pathway is further activated in mouse esophageal epithelium
above the baseline activity in the metaplasia phase. Consistent
with these data, we found overexpression of Nrf2 in adult esophagi
as compared to P7 esophagi (Figure 3E, G). Meanwhile, Pparb/d
and pAkt expression was correlated with Nrf2 expression
(Figure 3H, J; K, M). These data further supported the Pparb/d
and PI3K/Akt pathway as possible Nrf2 downstream effectors
promoting keratinization.
2. The role of Nrf2/Keap1 pathway during the
development of mouse esophagus
In specification phase, neither individual genes nor gene sets
associated with Nrf2/Keap1 pathway was selected by SAM or
GSA (Excel S2), suggesting that the Nrf2/Keap1 pathway was
unlikely involved in the specification phase during mouse
esophageal epithelial development.
a. Metaplasia phase. In the metaplasia phase, 37 Nrf2
target genes were selected as differentially expressed by multi-class
SAM (Excel S3). Fisher’s exact test with these genes showed that
the Nrf2/Keap1 pathway was significantly associated with
metaplasia phase (P=0.019422) (Table 1).
In order to further examine the role of Nrf2/Keap1 pathway in
the metaplasia phase, we profiled gene expression in P7 esophagi
from wild-type, Nrf2
2/2, Keap1
2/2 and Nrf2
2/2Keap1
2/2 mice.
At this time point, both Nrf2
2/2 and Nrf2
2/2Keap1
2/2 esophagi
appeared normal, whereas Keap1
2/2 esophagus appeared hyper-
keratotic (Figure 3A–D). Multi-class SAM analysis identified 526
DEGs (Excel S6). Two-class SAM confirmed that the major
difference among these four groups was between the wild-type and
Nrf2 in Mouse Esophageal Development
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2/2 esophagi (Excel S6). In agreement with these data,
hierarchical clustering analysis and PCA analysis clearly demon-
strated separation of the Keap1
2/2 esophagi from others (Figure
S4). Between wild-type and Nrf2
2/2 esophagi, only one gene
(Rbm45) was up-regulated, and three genes including Nrf2 were
down-regulated in Nrf2
2/2 esophagi. Between wild-type and
Nrf2
2/2Keap1
2/2esophagi, 19 genes were up-regulated and 10
genes including Nrf2, Upk3a and Krt17 were down-regulated in
Nrf2
2/2Keap1
2/2 esophagi. In constrast, 309 genes were up-
regulated and 346 genes down-regulated in Keap1
2/2 esophagi as
compared with wild-type esophagi. Among the up-regulated
genes, many classical Nrf2 target genes were enriched, such as
Nqo1, Gclm, Gclc, Gsts, Cat, Cyps, Mts, Mgsts, Aldhs, Cess and Abccs,
indicating Nrf2 superactivity. Keratinization-related genes such as
Sprr2h, Krt84, Ptgs2, Casp14 and Ppard were also up-regulated in
Keap1
2/2 esophagi. These data suggest that although the Nrf2/
Keap1 pathway was involved in the metaplasia phase as shown
above, Nrf2
2/2 did not have any significant impact on gene
expression in the esophagus. This observation may be explained
by compensation by other genes or a low baseline activity in this
phase. However, hyperactive Nrf2 due to Keap1
2/2 activated the
Nrf2/Keap1 pathway in the esophagus, and hence up-regulated
downstream target genes.
Among the 10 knowledge-based gene sets, Fisher’s exact test
identified six gene sets significantly different in Keap1
2/2 esophagi
as compared to wild-type esophagi: keratinized layer genes, EDC
genes, P63 target genes, Pax9 target genes, Sox2 target genes and
Nrf2/Keap1 pathway genes (Table 1). As expected, the Nrf2/
Keap1 pathway genes were highly significant (p=1.8610
214).
The keratinized layer genes, EDC genes and Pax9 target genes
were known to be associated with keratinization of stratified
squamous epithelium. These data were consistent with the
phenotype of esophageal hyperkeratosis in Keap1
2/2 mice.
An interesting question is why Keap1
2/2 mice developed
esophageal hyperkeratosis. Two-class GSA analysis was performed
to identify gene sets associated with the Keap1
2/2 esophagi as
compared with wild-type esophagi. Among the enriched gene sets
(Excel S6), the Nrf2/Keap1 transcription factors were significantly
up-regulated in Keap1
2/2 esophagi (Nfe2, Nrf2, Srebp1), as well as
Nrf2-relevant metabolism GO gene sets (GO_666, GO_1221,
GO_1333, GO_1374, GO_1408, GO_1418) and canonical
pathway gene sets (CP_29, CP_67, CP_68, CP_71, CP_429,
CP_530, CP_625, CP_626). In addition to these, Ppar pathway
(CP_80 and CP_101) and PI3K/Akt pathway (CP_629 and
Table 1. Differential expression of knowledge-based gene sets in the mouse esophagus in the metaplasia phase.
Samples Knowledge-based gene set
No. of genes in the
gene set
No. of genes in array
dataset No. of DEGs P value
Wild-type E11.5 vs E15.5 vs P0 vs P7 Basal lamina genes 40 29 2 0.222
Basal layer genes 14 10 1 0.267
Spinous layer genes 11 7 0 1.000
Granular layer genes 16 10 1 0.267
Keratinized layer genes 39 14 4 6.9E-4
EDC genes 58 21 3 0.029
Nrf2/Keap1 pathway genes 281 181 31 1.8E-14
P63 target genes 59 39 4 0.031
Pax9 target genes 23 13 3 0.007
Sox2 target genes 141 80 6 0.036
Wild-type vs Keap1
2/2 at P7 Basal lamina genes 40 29 16 3.0E-7
Basal layer genes 14 10 4 0.041
Granular layer genes 16 10 4 0.043
Spinous layer genes 11 7 1 0.661
Keratinized layer genes 39 14 9 2.6E-5
EDC genes 58 21 9 0.001
Nrf2/Keap1 pathway genes 281 181 37 0.019
P63 target genes 59 39 21 8.9E-9
Pax9 target genes 23 11 9 1.1E-6
Sox2 target genes 141 80 20 0.008
doi:10.1371/journal.pone.0036504.t001
Figure 2. Involvement of the Wnt pathway in the development
of mouse esophageal epithelium. (A) X-Gal staining of E11.5 and
E13.5 esophagi of BAT-GAL mice; (B) X-Gal staining of E13.5 esophagi of
TOP-GAL mice. Es, esophagus; Tr, trachea; Ep, epithelium; Me,
mesenchyme; Lu, lung.
doi:10.1371/journal.pone.0036504.g002
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2/2 esophagi, suggesting
potential roles of these pathways in superactive Nrf2-induced
esophageal hyperkeratosis in Keap1
2/2 mice. Real-time PCR
showed that Ppard was up-regulated and Pten down-regulated in
Keap1
2/2 esophagus, while keratinization-associated genes (Calm4
and Sbsn) were up-regulated (Figure S6).
Among three Ppar isoforms, Pparb/d activation is known to
cause terminal differentiation of keratinocytes [25], and Pparb/d
was up-regulated in Keap1
2/2 esophagi as compared with wild-
type esophagi (Excel S6). Keratinocyte-specific deficiency of Pten
caused Akt activation, and subsequently resulted in postnatal
death due to esophageal hyperkeratosis [26]. Here we examined
expression of Nrf2, Pparb/d and pAkt in the P7 esophageal
epithelium of wild-type and Keap1
2/2 mice. Consistent with the
expression pattern reported in the literature [27], Nrf2 was found
to translocate into the nuclei of esophageal epithelial cells in
Keap1
2/2 mice (Figure 3E, F). Corresponding to Nrf2 activation,
Pparb/d and pAkt were also overexpressed in the cytoplasm and
nuclei (Figure 3H, I; K, L). These data suggested that hyperactive
Nrf2 might promote esophageal hyperkeratosis in Keap1
2/2 mice
through activation of the Pparb/d and PI3K/Akt pathway.
b. Maturation phase. Further analysis of adult wild-type
and Nrf2
2/2 esophagi showed that 11 genes were up-regulated
and 25 down-regulated (including Nrf2 and its target genes), in
Nrf2
2/2 esophagi (Excel S7). Among these 25 genes, Akr1b8, Nqo1,
Gstm3, Nrf2, Gsta3, Gstm1 and Gclc are known as classical Nrf2
target genes. Hierarchical clustering and PCA analysis clustered
wild-type and Nrf2
2/2 esophagi separately (Figure S5). Based on
three lines of evidence, we concluded that Nrf2 was mainly
involved in maturation phase from P7 to adulthood: (1) there was
little difference in gene expression between wild-type and Nrf2
2/2
esophagus at P7; (2) Nrf2/Keap1 pathway genes were differen-
tially expressed between P7 and adult esophagus of wild-type mice;
(3) Nrf2/Keap1 pathway genes were differentially expressed
between adult wild-type and Nrf2
2/2 mice. These genes are
known to function in detoxification and anti-oxidative defense.
Discussion
This study clearly demonstrated a complex mechanism involv-
ing many genes and pathways at each phase during the
development of mouse esophageal epithelium. There was a
baseline activity of the Nrf2/Keap1 pathway in the metaplasia
phase, and a higher activity in the maturation phase. Hyperactive
Nrf2 in Keap1
2/2 mice resulted in esophageal hyperkeratosis,
probably through activation of the Pparb/d and PI3K/Akt
pathway.
Our data were consistent with previous studies on mouse
esophageal development. P63 and Sox2 were expressed in the
mouse esophagus prior to E11.5, suggesting their critical roles in
esophageal specification [6]. Pax9 was expressed in the mouse
esophagus at E13.5 [28] and was essential for expression of
Figure 3. Esophageal hyperkeratosis due to Nrf2 superactivation in Keap1
2/2 esophagus. P7 esophagi of a wild-type mouse (A), a Nrf2
2/2
mouse (B), a Keap1
2/2 mouse (C), and a Nrf2
2/2Keap1
2/2 mouse (D), were stained for H&E. Expression of Nrf2 (E–G), Pparc/d (H–J) and pAkt (K–L)
were shown in the esophagi of P7 wild-type mouse, P7 Keap1
2/2 mouse and adult wild-type mouse. Size bar=50 mm.
doi:10.1371/journal.pone.0036504.g003
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[29]. The Wnt pathway promoted respiratory progenitor identity
in the mouse foregut, and continuous activation of the Wnt
pathway resulted in the reprogramming of esophagus and stomach
to a lung endoderm progenitor fate [30,31]. This explains why the
Wnt pathway became inactive in the esophagus later in the
metaplasia phase (Figure 2). The NFkB pathway, especially IKKa,
played an important role in keratinocyte differentiation [32].
Hedgehog pathway participated in esophageal development by
signaling from the endoderm to the mesoderm [33,34]. Bmp
pathway was inhibited between E10.5 and E14.5 to allow
metaplasia to take place. After E14.5–E15.5, active Bmp signaling
is required for further differentiation of esophageal epithelium [4].
Our main goal in this study was to determine the role of the
Nrf2/Keap1 pathway in the development of esophageal epithe-
lium. Using gene microarray analysis with wild-type mouse
samples, we found that the Nrf2/Keap1 pathway was likely
uninvolved in the specification phase (Excel S2). Starting from the
metaplasia phase, there was a baseline activity of the Nrf2/Keap1
pathway. However, Nrf2
2/2 did not have a significant impact on
gene expression and morphology of esophageal epithelium at P7
(Excel S6). We believe that the Nrf2/Keap1 pathway is mainly
involved in the development of esophageal epithelium in the
maturation phase (Excel S5). As compared with wild-type adult
mice, Nrf2
2/2 reduced expression of multiple downstream genes
whose major functions are detoxification and anti-oxidative
defense (Excel S7).
It is unknown why hyperactive Nrf2 in Keap1
2/2 mice caused
hyperkeratosis of the esophageal epithelium at P7. Similar to the
esophagus, the skin was also hyperkeratic in Keap1
2/2 mice [15],
suggesting similar mechanisms of hyperkeratosis in the skin and
the esophagus. Mechanistically, Nrf2 is known to regulate Krt16/
Krt17 expression through MAP kinases [35]. In this study, GSA
analysis identified two potential candidate pathways responsible
for hyperkeratosis: Ppar signaling and PI3K/Akt pathway (Excel
S6). Although Pparc is a direct transcriptional target of Nrf2 [36],
Pparb/d is more likely to be the isoform involved among the three
Ppar isoforms because Pparb/d agonists were known to cause
terminal differentiation of keratinocytes in vitro [25,37] and dermal
hyperkeratosis in vivo [38]. While Pparb/d
2/2 inhibited epidermal
keratinization, transgenic overexpression promoted epidermal
hyperkeratosis [39,40]. Several Nrf2 target genes (Aldh3a1, Gstm3,
Gsto1, Gsta1, Aldh9a1) were also known to be regulated by Pparb/d
[41]. In this study, we confirmed overexpression of Pparb/d in
Keap1
2/2 esophagus relative to wild-type esophagus at P7. Adult
esophagus also expressed a higher level of Pparb/d than P7
esophagus, which is less keratinized (Figure 3 H, I, J). These data
supported the hypothesis that Keap1
2/2 might produce esophageal
hyperkeratosis through activation of Pparb/d.
Other than Pparb/d, the PI3K/Akt pathway may also
contribute to hyperactive Nrf2-induced esophageal hyperkeratosis
(Figure 3 K, L, M). Keratinocyte-specific deficiency of Pten caused
Akt activation, and subsequently resulted in postnatal death due to
esophageal hyperkeratosis [26]. Notch pathway is the third
candidate. Recent studies demonstrated regulation of the Notch
pathway by Nrf2 [42] and participation of the Notch pathway in
terminal differentiation of esophageal epithelium [43]. Further
studies are warranted to identify downstream effectors that
contribute to esophageal hyperkeratosis.
Esophageal hyperkeratosis in humans may develop as a result of
vitamin A deficiency, vitamin E excess, HPV-induced papilloma-
tosis, Darier’s disease, tylosis or caustic injury [44]. It is also
commonly seen in rodent models of esophageal cancer or reflux
esophagitis. We suspect that the Nrf2/Keap1 pathway is involved
in some of these cases. For example, retinoic acid is known to
inhibit Nrf2 [45]. Vitamin A deficiency may cause Nrf2
hyperactivity and esophageal hyperkeratosis. In addition to a
mechanistic understanding of human esophageal disease, manip-
ulation of the Nrf2/Keap1 pathway may provide a novel way of
enhancing the protective barrier of the esophageal epithelium.
The keratinized layer is the major protective layer against physical
stress and chemical injuries [46]. Terminally differentiated
keratinocytes express proteins which can provide protection by
quenching reactive oxygen species [47]. In fact, sulforaphane, a
chemical activator of Nrf2, restores skin integrity in an epider-
molysis bullosa simplex model (created by Krt5 or Krt14 mutation)
by activating Krt17 expression [48]. Similarly, Pparb/d activation
can also enhance the epidermal permeability barrier [25,38].
This study has many potential implications for future studies.
Several developmental pathways involved in esophageal develop-
ment were found to be active at an early time point and then
became inactive later on (Table 2). However, these pathways are
known to be involved in esophageal diseases such as Barrett’s
esophagus and esophageal cancer, suggesting that tight spatiotem-
poral regulation of these pathways is critical for both development
and disease [49,50,51,52,53,54]. Further understanding of these
pathways during development will shed light on molecular
mechanisms of esophageal diseases.
Supporting Information
Figure S1 Hierarchical clustering analysis and PCA analysis of
gene expression array data of wild-type mouse definitive
endoderm (E8.25) and esophagi (E11.5): (A) clustering analysis;
(B) PCA analysis.
(TIF)
Figure S2 Hierarchical clustering analysis and PCA analysis of
gene expression array data of wild-type mouse esophagi (E11.5,
E15.5, P0, P7): (A) clustering analysis; (B) PCA analysis.
(TIF)
Figure S3 Real-time PCR analysis of mRNA expression in wild-
type mouse esophagi: relative mRNA levels of Pax9 and its target
genes (Sbsn, Calm4) in mouse esophageal epithelium of E15.5, P0,
P7 and adult mice.
(TIF)
Table 2. Pathway changes in the three phases of mouse
esophageal development.
Signaling pathway Developmental phase
Specification Metaplasia Maturation
Wnt qq Q
Hedgehog qQ
TGFb qQ
BMP
a Qq
NFkB qQ
Notch
b q
Nrf2/Keap1 q
Note: q and q indicate up- or down-regulation, respectively.
aReference [4].
bReference [43].
doi:10.1371/journal.pone.0036504.t002
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gene expression array data of P7 mouse esophagi (wild-type,
Nrf2
2/2, Keap1
2/2, Nrf2
2/2Keap1
2/2): (A) clustering analysis; (B)
PCA analysis.
(TIF)
Figure S5 Hierarchical clustering analysis and PCA analysis of
gene expression array data of mouse esophagi (wild-type adult,
Nrf2
2/2 adult): (A) clustering analysis; (B) PCA analysis.
(TIF)
Figure S6 Real-time PCR analysis of mRNA expression in wild-
type and Keap1
2/2 mouse esophagi: relative mRNA levels of Pax9,
Sbsn, Calm4, Ppard, Pten and Akt2 in the whole esophagi of wild type
and Keap1
2/2 mice at P7.
(TIF)
Excel S1 Knowledge-based gene sets and references.
(XLS)
Excel S2 Differential gene expression in the specification phase
during wild-type mouse esophageal development: (1) Raw gene
expression array data after data pre-processing (E8.25 endoderm
and E11.5 esophagus); (2) SAM analysis of differentially expressed
genes (E8.25 endoderm vs E11.5 esophagus); (3) GSA analysis of
differentially expressed gene sets (E8.25 endoderm vs E11.5
esophagus); (4) Fisher’s exact test of knowledge-based gene sets
(E8.25 endoderm vs E11.5 esophagus).
(XLSX)
Excel S3 Differential gene expression in the metaplasia phase
during wild-type mouse esophageal development: (1) Raw gene
expression array data after data pre-processing (E11.5, E15.5, P0
and P7); (2) SAM analysis of differentially expressed genes (E11.5
vs E15.5 vs P0 vs P7); (3) GSA analysis of differentially expressed
gene sets (E11.5 vs E15.5 vs P0 vs P7).
(XLSX)
Excel S4 Dynamic expression of eighteen gene expression
patterns and nine knowledge-based gene sets in the metaplasia
phase.
(XLSX)
Excel S5 Differential gene expression in the maturation phase
during the development of wild-type mouse esophageal epitheli-
um: (1) Raw gene expression array data after data pre-processing
(P7 and adult esophagus); (2) SAM analysis of differentially
expressed genes (P7 vs adult esophagus); (3) GSA analysis of
differentially expressed gene sets (P7 vs adult esophagus); (4)
Fisher’s exact test of knowledge-based gene sets (P7 vs adult
esophagus).
(XLSX)
Excel S6 Differential gene expression at P7 between wild-type
mice, Nrf2
2/2 mice, Keap1
2/2 mice, and Nrf2
2/2Keap1
2/2 mice:
(1) Raw gene expression array data after data pre-processing (wild-
type P7, Nrf2
2/2 P7, Keap1
2/2 P7, Nrf2
2/2Keap1
2/2 P7); (2)
SAM analysis of differentially expressed genes (wild-type P7 vs
Nrf2
2/2 P7 vs Keap1
2/2 P7 vs Nrf2
2/2Keap1
2/2 P7); (3) GSA
analysis of differentially expressed gene sets (wild-type P7 vs
Keap1
2/2 P7).
(XLSX)
Excel S7 Differential gene expression between esophageal
epithelium of adult wild-type and Nrf2
2/2 mice: (1) Raw gene
expression array data after data pre-processing (wild-type adult,
Nrf2
2/2 adult); (2) SAM analysis of differentially expressed genes
(wild-type adult vs Nrf2
2/2 adult).
(XLSX)
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